Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 11/20 | 0.58 |
| ▸ | MGAM | O43451 | 10/20 | 0.58 |
| ▸ | AMY1A | P0DUB6 | 10/20 | 0.58 |
| ▸ | SI | P14410 | 10/20 | 0.58 |
| ▸ | MGAM2 | Q2M2H8 | 10/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | F2 | P00734 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.58 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.56 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.54 |
| ▸ | F12 | P00748 | 6/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | MIF | P14174 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL535509 | 0.83 | GAA (0.58) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL13604194 | 0.82 | GAA (0.52) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL17994056 | 0.81 | GAA (0.57) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL10621117 | 0.80 | GAA (0.64) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL17994057 | 0.80 | GAA (0.55) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL6402628 | 0.80 | GAA (0.55) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL706083 | 0.80 | MGAM (0.68) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL4250719 | 0.80 | GAA (0.68) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL19911632 | 0.79 | KMT2A (0.46) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL19911622 | 0.79 | KCNMA1 (0.57) | GAAMGAMAMY1ASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024024935-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE HAVING ANTINEOPLASTIC EFFECT | 第一三共株式会社 | 2024-02-01 | — | — | WO | claimed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | claimed |
| EP-2985286-B1 | MIDBODY OF TICAGRELOR AND PREPARATION METHOD THEREFOR, AND PREPARATION METHOD FOR TICAGRELOR | JIANGSU HENGRUI MEDICINE CO (CN) | 2017-10-11 | — | — | EP | claimed |
| US-9359366-B2 | Intermediate of Ticagrelor and preparation method therefor, and preparation method for Ticagrelor | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2016-06-07 | — | — | US | claimed |
| US-20160052928-A1 | INTERMEDIATE OF TICAGRELOR AND PREPARATION METHOD THEREFOR, AND PREPARATION METHOD FOR TICAGRELOR | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2016-02-25 | — | — | US | claimed |
| EP-2985286-A1 | MIDBODY OF TICAGRELOR AND PREPARATION METHOD THEREFOR, AND PREPARATION METHOD FOR TICAGRELOR | Jiangsu Hengrui Medicine Co. Ltd. (CN) | 2016-02-17 | — | — | EP | claimed |
| WO-2025079669-A1 | METHOD FOR PRODUCING CONDUCTIVE PARTICLES, AND CONDUCTIVE POWDER | 日本化学工業株式会社 | 2025-04-17 | — | — | WO | disclosed |
| WO-2024101306-A1 | CONDUCTIVE PARTICLES, METHOD FOR MANUFACTURING SAME, CONDUCTIVE MATERIAL, AND CONNECTION STRUCTURE USING SAME | 日本化学工業株式会社 | 2024-05-16 | — | — | WO | disclosed |
| WO-2024043047-A1 | CONDUCTIVE PARTICLES, PRODUCTION METHOD THEREFOR, AND CONDUCTIVE MEMBER | 日本化学工業株式会社 | 2024-02-29 | — | — | WO | disclosed |
| WO-2024024935-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE HAVING ANTINEOPLASTIC EFFECT | 第一三共株式会社 | 2024-02-01 | — | — | WO | disclosed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | disclosed |
| US-11311934-B2 | Covered particle | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2022-04-26 | — | — | US | disclosed |
| US-20210174987-A1 | COVERED PARTICLE | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2021-06-10 | — | — | US | disclosed |
| US-7470815-B1 | Selective neuronal nitric oxide synthase inhibitors | NORTHWESTERN UNIVERSITY (US) | 2008-12-30 | — | — | US | disclosed |
| US-20050159363-A1 | Selective neuronal nitric oxide synthase inhibitors | SILVERMAN RICHARD B (US) | 2005-07-21 | — | — | US | disclosed |
| US-6803486-B2 | PEPTIDOMIMETIC; N-AMINOBUTYL-N'-NITROGUANIDINE DERIVATIVES | NORTHWESTERN UNIVERSITY | 2004-10-12 | — | — | US | disclosed |
| US-6685995-B1 | LOW VOLTAGE, WIDE TEMPERATURE RANGE DRIVING; HIGH SPEED RESPONSE | CHISSO CORPORATION (JP) | 2004-02-03 | — | — | US | disclosed |
| US-20030119751-A1 | Selective neuronal nitric oxide synthase inhibitors | NORTHWESTERN UNIVERSITY | 2003-06-26 | — | — | US | disclosed |
| WO-2003000198-A2 | SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS | NORTHWESTERN UNIVERSITY (US) | 2003-01-03 | — | — | WO | disclosed |
| EP-1053996-A1 | ESTER COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS AND LIQUID CRYSTAL DISPLAY DEVICES | CHISSO CORPORATION (JP) | 2000-11-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159363-A1 | Selective neuronal nitric oxide synthase inhibitors | NOS1, NOS3, NOS2 | GAA 2689/4885MGAM 4268/4885AMY1A 4402/4885 |
| US-20160052928-A1 | INTERMEDIATE OF TICAGRELOR AND PREPARATION METHOD THEREFOR, AND PREPARATION METHOD FOR TICAGRELOR | POR, CYP2C19, TKFC | GAA 873/4885MGAM 1874/4885AMY1A 2957/4885 |
| US-20030119751-A1 | Selective neuronal nitric oxide synthase inhibitors | NOS1, NOS3, NOS2 | GAA 2689/4885MGAM 4268/4885AMY1A 4402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.